2024
DOI: 10.1016/j.it.2024.03.005
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of host immunity by sensory neurons

Telma Saraiva-Santos,
Tiago H. Zaninelli,
Felipe A. Pinho-Ribeiro
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 83 publications
0
2
0
Order By: Relevance
“…Tissue-agnostic approaches such as selective or non-selective inhibition of Trk (larotrectinib and entrectinib) have been approved by the FDA for fusion cancers and could be considered as future therapies to target nerves in sarcoma 54 . More recently, the FDA approval for antibodies against the CGRP (erenumab and fremanezumab) to treat chronic migraines [55][56][57][58] , brings up an exciting possibility of drug repurposing to ameliorate sarcoma progression and bone Sensory neurons modulate the tumor microenvironment via secondary mechanisms such as promoting vascularization 60 . In our xenograft orthotopic model of OS, we observed that blocking of sensory (TrkA + /CGRP + ) nerve fibers resulted in marked reduction in tumor-associated blood vessels (EMCN + /CD31 + ) and reduced pro-vasculogenic ligand VEGFA, as described in other contexts 18,25,61,62 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Tissue-agnostic approaches such as selective or non-selective inhibition of Trk (larotrectinib and entrectinib) have been approved by the FDA for fusion cancers and could be considered as future therapies to target nerves in sarcoma 54 . More recently, the FDA approval for antibodies against the CGRP (erenumab and fremanezumab) to treat chronic migraines [55][56][57][58] , brings up an exciting possibility of drug repurposing to ameliorate sarcoma progression and bone Sensory neurons modulate the tumor microenvironment via secondary mechanisms such as promoting vascularization 60 . In our xenograft orthotopic model of OS, we observed that blocking of sensory (TrkA + /CGRP + ) nerve fibers resulted in marked reduction in tumor-associated blood vessels (EMCN + /CD31 + ) and reduced pro-vasculogenic ligand VEGFA, as described in other contexts 18,25,61,62 .…”
Section: Discussionmentioning
confidence: 99%
“…Sensory neurons modulate the tumor microenvironment via secondary mechanisms such as promoting vascularization 60 . In our xenograft orthotopic model of OS, we observed that blocking of sensory (TrkA + /CGRP + ) nerve fibers resulted in marked reduction in tumor-associated blood vessels (EMCN + /CD31 + ) and reduced pro-vasculogenic ligand VEGFA, as described in other contexts 18,25,61,62 .…”
Section: Discussionmentioning
confidence: 99%